Header Leaderboard Ad

Collapse

Tech Summary: Roche's 454 GS20 / FLX / Titanium

Collapse

Announcement

Collapse
No announcement yet.
This is a sticky topic.
X
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Tech Summary: Roche's 454 GS20 / FLX / Titanium

    There isn't anything here yet!

    If you are interested in writing a tech summary, just post it below and I will rearrange the thread as appropriate.

    Alternatively if anyone wants to post tech sheets, manuals, etc, I will write it. I just don't know enough of it beyond "pyrosequencing, picotiter plates, and a ton of beads".

  • #2
    quick summary of titanium from 454 site

    Needed this for something else may be incomplete or wrong but ..

    400-600 million high-quality, filter-passed bases per run
    10 hours
    average length 400 bp
    more than 1x10^6 reads

    a cluster from roche is recommended for signal processing from www.pssclabs.com. It looks like image processing will still happen on the GS-FLX and 9G of cwf (wells) files need to go the the cluster

    from what I can tell it is a 5 node system (20 cores) the only specs I can find say redhat with either openMPI or MPI2 (mpiexec), SunGrid as scheduler

    runs will be 35GB (26GB images)

    A test data-set with a configuration tester is promised soon

    Rumor has it that bead breaking will be via centrifuge in the new protocol

    Comment


    • #3
      I am confused by this .. "pyrosequencing from illumina" !
      --
      bioinfosm

      Comment


      • #4
        Originally posted by bioinfosm View Post
        I am confused by this .. "pyrosequencing from illumina" !
        Confused here too.
        Illmunia currently produces 15-20GB from single run of paired-end already.
        Protocol will be available sometime early next year.

        Comment


        • #5
          Originally posted by bioinfosm View Post
          I am confused by this .. "pyrosequencing from illumina" !
          Originally posted by monad View Post
          Confused here too.
          Illmunia currently produces 15-20GB from single run of paired-end already.
          Protocol will be available sometime early next year.
          They bought Avantome.

          Comment


          • #6
            SV

            Look out for the SV prep on titanium. There is a pretty serious typo under the DNA capture step. 3.2.7 the volume to evenly distribute capture beads is off. It says 40ul per rxn, it's really more like 70+ul. In fact completely ignore this section and prep each rxn in individual 1.7ml tubes. The roche tech agrees with me... just wash with 3-400ul of cap bead wash buff so you don't run out.... Then again, does Ti even work as advertised?

            Comment


            • #7
              Hi,

              You have already summary out the tech of Roche's 454 GS20 / FLX / Titanium?
              I interesting about it too

              Originally posted by ECO View Post
              There isn't anything here yet!

              If you are interested in writing a tech summary, just post it below and I will rearrange the thread as appropriate.

              Alternatively if anyone wants to post tech sheets, manuals, etc, I will write it. I just don't know enough of it beyond "pyrosequencing, picotiter plates, and a ton of beads".

              Comment


              • #8
                Cangs

                Does anybody already have to use CANGS? If yes he could explain to me why it filters primers sequences while this filter is already made by 454?

                Comment


                • #9
                  With Illumina now going to 300bp, does there remain a viable role for 454?

                  Comment


                  • #10
                    Originally posted by scrosby View Post
                    With Illumina now going to 300bp
                    link?

                    --
                    Phillip

                    Comment


                    • #11
                      Forgive me...

                      I should have said 'soon' going to to 150 PE. Before the end of the year, I believe?

                      Comment


                      • #12
                        Actually, with the results I saw from recent v3 runs I was wondering if anyone had pushed out past 100 nt on HiSeq chemistry already?

                        --
                        Phillip

                        Comment

                        Latest Articles

                        Collapse

                        • seqadmin
                          A Brief Overview and Common Challenges in Single-cell Sequencing Analysis
                          by seqadmin


                          ​​​​​​The introduction of single-cell sequencing has advanced the ability to study cell-to-cell heterogeneity. Its use has improved our understanding of somatic mutations1, cell lineages2, cellular diversity and regulation3, and development in multicellular organisms4. Single-cell sequencing encompasses hundreds of techniques with different approaches to studying the genomes, transcriptomes, epigenomes, and other omics of individual cells. The analysis of single-cell sequencing data i...

                          01-24-2023, 01:19 PM
                        • seqadmin
                          Introduction to Single-Cell Sequencing
                          by seqadmin
                          Single-cell sequencing is a technique used to investigate the genome, transcriptome, epigenome, and other omics of individual cells using high-throughput sequencing. This technology has provided many scientific breakthroughs and continues to be applied across many fields, including microbiology, oncology, immunology, neurobiology, precision medicine, and stem cell research.

                          The advancement of single-cell sequencing began in 2009 when Tang et al. investigated the single-cell transcriptomes
                          ...
                          01-09-2023, 03:10 PM
                        • seqadmin
                          AVITI from Element Biosciences: Latest Sequencing Technologies—Part 6
                          by seqadmin
                          Element Biosciences made its sequencing market debut this year when it released AVITI, its first sequencer. The AVITI System uses avidity sequencing, a novel sequencing chemistry that delivers higher quality data, decreases cycle times, and requires lower reagent concentrations. This new instrument reportedly features lower operating and start-up costs while maintaining quality sequencing.

                          Read type and length
                          AVITI is a short-read benchtop sequencer that also offers an innovative...
                          12-29-2022, 10:44 AM

                        ad_right_rmr

                        Collapse
                        Working...
                        X